Medilines Distributors Incorporated: Initial Public Offering - Release of Shares under Lock-Up
July 28, 2022 at 05:18 am
Share
NOTICE
Subject
Medilines Distributors Incorporated: Initial Public Offering - Release of Shares under Lock-Up
Company Name
Medilines Distributors Incorporated
Security Details
Type of Security
Stock Symbol
Par Value
Common Shares
MEDIC
Php 0.25
Reference(s)
LN00368-2021 dated December 3, 2021
Type of Transaction(s)
Initial Public Offering
Lock-up Details
Duration of Lock-up
365 days
Applicable Lock-up Rule
Article III, Part D, Section 2 of the Consolidated Listing and Disclosure Rules, as amended
Escrow Agent
PNB acting through its Trust Banking Group
Date of Execution of Escrow Agreement
Nov 16, 2021
Details of the Mandatory Lock-up
Name of Shareholder
No. of Shares
Stock Symbol
Percentage
Maria Patricia Dolor V. Yambing
400
MEDIC
-
Norman K. Macapagal
400
MEDIC
-
Fernando Sixto V. Segovia
400
MEDIC
-
Brian N. Edang
400
MEDIC
-
Gerardo J. Guerrero
400
MEDIC
-
Details of the Voluntary Lock-up (if applicable)
Name of Shareholder
No. of Shares
Stock Symbol
Percentage
-
-
-
-
Total Shares to be Released from Lock-up
Stock Symbol
No. of Shares
MEDIC
2,000
Expiry of Lock-up
Aug 1, 2022
Effective Date of Tradability of the Shares
Aug 2, 2022
Other Relevant Information
As previously announced in LN00368-2021 dated December 3, 2021, in view of Medilines Distributors Incorporated's ("MEDIC" or the "Company") compliance with the lock-up requirement of the Exchange, 2,000 common shares were subject to a lock-up period of 365 days from full payment date of such shares.
In a letter dated July 25, 2022, Philippine National Bank, acting through its Trust Banking Group (the "Escrow Agent"), informed the Exchange that the lock-up period for the 2,000 MEDIC common shares owned by the above-mentioned Locked-up Shareholders will expire on August 1, 2022.
In view thereof, 2,000 MEDIC common shares that were held in escrow will be eligible for trading starting on Tuesday, August 2, 2022, subject to compliance with the Exchange's rule on lodgment of securities.
For your information and guidance.
Filed on behalf by:
Name
Norberto Moreno Jr.
Designation
Listings Department
Attachments
Original Link
Original Document
Permalink
Disclaimer
Medilines Distributors Inc. published this content on 28 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 July 2022 04:17:01 UTC.
Medilines Distributors, Inc. is a Philippines-based distributor of critical medical equipment to public and private healthcare facilities across the Philippines. Its products such as linear accelerators for cancer treatment, dialysis machines for treatment of kidney diseases, and imaging machines such as computerized tomography (CT), x-rays, and magnetic resonance imaging (MRI). It is focused on three core categories: diagnostics imaging, dialysis, and cancer therapy. It manufactures equipment in advanced therapy, which includes C-Arm, Cathlab, Robotics. Its Molecular Imaging, which includes PET CT and SPECT CT. Its renal care includes dialysis machines, consumables, and accessories. Its radiation therapy includes Varian Halcyon, and Varian True Beam. Its diagnostic imaging products include Multix Impact, Elara Max, Polymobil Plus, and Magnetom Skyra. Its brands include Siemens Healthineers for diagnostic imaging, B. Braun for dialysis, and Varian for cancer therapy.
MEDILINES DISTRIBUTORS INCORPORATED 
